Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.64 is 28% below its 5-year average of 14.72, near the low end of its 5-year range (8.72–22.09).
As of the fiscal period ended Tuesday, June 30, 2026. 30.64% below its 12-month average of 15.35.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.64.
CURRENT RATIO
10.64
CURRENT RATIO AVG TTM
15.35
CURRENT RATIO AVG 3Y
14.44
CURRENT RATIO AVG 5Y
14.72
CURRENT RATIO AVG 10Y
16.27
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-30.64%
CURRENT VS 3Y AVG
-26.30%
CURRENT VS 5Y AVG
-27.71%
CURRENT VS 10Y AVG
-34.57%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.49
median of 706 covered companies
CURRENT VS SECTOR MEDIAN
+205.44%
vs the sector median at left
Market Cap
$415.78M
Current Ratio
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$412.14M
Current Ratio
8.13
TTM Avg
16.34
3Y Avg
21.67
5Y Avg
17.16
Market Cap
$409.27M
Current Ratio
10.71
TTM Avg
7.83
3Y Avg
8.94
5Y Avg
8.94
Market Cap
$423.49M
Current Ratio
25.05
TTM Avg
8.87
3Y Avg
10.83
5Y Avg
12.06
Market Cap
$397.78M
Current Ratio
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neurogene Inc. (NGNE) | $416.01M | 10.64 | 15.35 | 14.44 | 14.72 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $415.78M | 9.89 | 6.34 | 6.34 | 6.34 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $412.14M | 8.13 | 16.34 | 21.67 | 17.16 |
| Shoulder Innovations, Inc. (SI)vs › | $409.27M | 10.71 | 7.83 | 8.94 | 8.94 |
| Prothena Corporation plc (PRTA)vs › | $423.49M | 25.05 | 8.87 | 10.83 | 12.06 |
| Carlsmed, Inc. (CARL)vs › | $404.24M | 8.84 | 7.23 | 5.35 | 5.35 |
| Myriad Genetics, Inc. (MYGN)vs › | $402.82M | 2.21 | 2.16 | 2.08 | 2.23 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $397.78M | 16.52 | 13.61 | 8.86 | 8.86 |
| NeoGenomics, Inc. (NEO)vs › | $435.40M | 3.60 | 3.12 | 4.79 | 5.52 |
| Editas Medicine, Inc. (EDIT)vs › | $438.18M | 3.19 | 3.65 | 4.66 | 6.11 |
Current Ratio
10.64
Quick Ratio
10.64
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.64 |
| 2026-03-31 | 13.08 |
| 2025-12-31 | 16.55 |
| 2025-09-30 | 18.39 |
| 2025-06-30 | 18.07 |
| 2025-03-31 | 21.03 |
| 2024-12-31 | 20.84 |
| 2024-09-30 | 9.09 |
| 2024-06-30 | 12.17 |
| 2024-03-31 | 14.74 |
| 2023-12-31 | 8.72 |
| 2023-09-30 | 15.33 |
| 2023-06-30 | 9.12 |
| 2023-03-31 | 11.97 |
| 2022-12-31 | 12.74 |
| 2022-09-30 | 10.63 |
| 2022-06-30 | 12.78 |
| 2022-03-31 | 17.16 |
| 2021-12-31 | 16.67 |
| 2021-09-30 | 17.40 |
| 2021-06-30 | 22.09 |
| 2021-03-31 | 21.57 |
| 2020-12-31 | 24.66 |
| 2020-09-30 | 20.88 |
| 2020-06-30 | 20.73 |
| 2020-03-31 | 24.92 |
| 2019-12-31 | 30.28 |
| 2019-09-30 | 26.35 |
| 2019-06-30 | 63.17 |
| 2019-03-31 | 20.81 |
| 2018-12-31 | 16.68 |
| 2018-09-30 | 8.12 |
| 2018-06-30 | 7.73 |
| 2018-03-31 | 10.07 |
| 2017-12-31 | 9.93 |
| 2017-09-30 | 17.23 |
| 2017-06-30 | 16.26 |
| 2017-03-31 | 21.02 |
| 2016-12-31 | 10.87 |
| 2016-09-30 | 17.12 |
